This I disagree with/ Third: We are once again
Post# of 22456
(Total Views: 429)
Posted On: 08/27/2021 9:36:38 AM
Re: critical cat #20717
This I disagree with/
For the first time they are chasing something that there were hired to chase.
See Pasaca agreement
"POCT ...technology is intended to part of our immediate commercialization focus."
"The Company recognized early in the advent of Covid-19 that we could use our proprietary technologies to design and develop a more sensitive lateral flow test kit using our unique quantum dot technologies. Over the past several months, we have expanded our biotech team and collaborated with our material scientists. As a result, we have now developed a point of care test platform (POCT) that we believe is more sensitive than current technologies. We believe it will provide analytic sensitivity that can rival PCR and provide quantitative results when warranted. We are currently developing 1) LFTs (lateral flow test kits) for TBI (traumatic brain injury, aka concussions), 2) a multiplex test that detects Covid-19, Flu and RSV (Respiratory Syncytial Virus), and 3) a vaccine validator to thwart counterfeit vaccines and validate vaccine efficacy. This test kit technology uses a unique quantum dot as a signal amplifier and can give a visual test result indication using a low-cost UV light source or using our POCT reader to interface with a P.C. or a smartphone. This reader is designed to provide a binary readout indicating positive or negative and a quantitative result indicating the level of viral loading. We believe that this can be very valuable, particularly in viruses like Covid-19, where a current test cannot reliably identify low viral loading, which is often the case in asymptomatic individuals who are the most likely to spread the virus unknowingly."
I guess it is all how you look at it.
If QMC put out only this PR, QMC is currently developing " LFTs (lateral flow test kits) for TBI (traumatic brain injury, aka concussions),"
No one would give it much credibility.
Add this "Canada-based biotech company that has identified and has a patent-pending on several biomarker candidates that will be used to develop the TBI POC"
The possibility becomes very creditable.
Quote:
Third: We are once again chasing the carrot of something new in development.
For the first time they are chasing something that there were hired to chase.
See Pasaca agreement
"POCT ...technology is intended to part of our immediate commercialization focus."
"The Company recognized early in the advent of Covid-19 that we could use our proprietary technologies to design and develop a more sensitive lateral flow test kit using our unique quantum dot technologies. Over the past several months, we have expanded our biotech team and collaborated with our material scientists. As a result, we have now developed a point of care test platform (POCT) that we believe is more sensitive than current technologies. We believe it will provide analytic sensitivity that can rival PCR and provide quantitative results when warranted. We are currently developing 1) LFTs (lateral flow test kits) for TBI (traumatic brain injury, aka concussions), 2) a multiplex test that detects Covid-19, Flu and RSV (Respiratory Syncytial Virus), and 3) a vaccine validator to thwart counterfeit vaccines and validate vaccine efficacy. This test kit technology uses a unique quantum dot as a signal amplifier and can give a visual test result indication using a low-cost UV light source or using our POCT reader to interface with a P.C. or a smartphone. This reader is designed to provide a binary readout indicating positive or negative and a quantitative result indicating the level of viral loading. We believe that this can be very valuable, particularly in viruses like Covid-19, where a current test cannot reliably identify low viral loading, which is often the case in asymptomatic individuals who are the most likely to spread the virus unknowingly."
I guess it is all how you look at it.
Quote:
Now a company in Canada is in play.
If QMC put out only this PR, QMC is currently developing " LFTs (lateral flow test kits) for TBI (traumatic brain injury, aka concussions),"
No one would give it much credibility.
Add this "Canada-based biotech company that has identified and has a patent-pending on several biomarker candidates that will be used to develop the TBI POC"
The possibility becomes very creditable.
(0)
(0)Quantum Materials Corp. (QTMM) Stock Research Links
Scroll down for more posts ▼